| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | TRERF1 KMT2C NCOA6 ARID1B KAT6A MED12L NCOA1 SMARCC2 MAML2 ARID1A KAT6B SS18 CREBBP TRIP4 MAML3 EP300 | 2.98e-15 | 303 | 67 | 16 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 KMT2C NCOA6 ARID1B KAT6A MED12L NCOA1 SMARCC2 MAML2 ARID1A KAT6B SS18 CREBBP TRIP4 MAML3 EP300 | 3.74e-11 | 562 | 67 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 KMT2C NCOA6 ARID1B KAT6A MED12L SYN1 NCOA1 SMARCC2 MAML2 ARID1A KAT6B KLF4 SS18 CREBBP TRIP4 MAML3 EP300 GAB1 | 4.78e-09 | 1160 | 67 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 KMT2C NCOA6 ARID1B KAT6A MED12L SYN1 NCOA1 SMARCC2 TAB2 MAML2 ARID1A KAT6B KLF4 SS18 CREBBP TRIP4 MAML3 EP300 GAB1 | 1.01e-08 | 1356 | 67 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.54e-07 | 15 | 67 | 4 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 7.62e-07 | 51 | 67 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 ARID1B TOX ATRX EGFR KAT6A NCOA1 SMARCC2 ARID1A KAT6B KLF4 CREBBP EP300 | 8.81e-07 | 739 | 67 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.12e-06 | 55 | 67 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.73e-06 | 60 | 67 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.38e-06 | 78 | 67 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.02e-05 | 417 | 67 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.11e-05 | 2 | 67 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.11e-05 | 2 | 67 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.05e-05 | 167 | 67 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.28e-05 | 582 | 67 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.37e-05 | 102 | 67 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.60e-05 | 104 | 67 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 3.23e-05 | 54 | 67 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.32e-05 | 3 | 67 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 NCOA6 KAT6A MED12L AHR NCOA1 ARID1A KLF4 CREBBP TRIP4 EP300 | 3.81e-05 | 753 | 67 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.87e-05 | 187 | 67 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.60e-05 | 21 | 67 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 5.23e-05 | 61 | 67 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.07e-04 | 140 | 67 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.19e-04 | 229 | 67 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.46e-04 | 238 | 67 | 6 | GO:0016747 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 3.93e-04 | 9 | 67 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 7.50e-04 | 53 | 67 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 1.64e-03 | 18 | 67 | 2 | GO:1990226 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.03e-03 | 20 | 67 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | p53 binding | 2.21e-03 | 77 | 67 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 2.68e-03 | 23 | 67 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 2.68e-03 | 23 | 67 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.82e-03 | 891 | 67 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | SMAD binding | 3.03e-03 | 86 | 67 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 3.69e-03 | 27 | 67 | 2 | GO:0004709 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 3.69e-03 | 27 | 67 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | nucleosome binding | 4.38e-03 | 98 | 67 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 6.85e-03 | 37 | 67 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 6.85e-03 | 37 | 67 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 7.67e-03 | 120 | 67 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.95e-03 | 127 | 67 | 3 | GO:0008094 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 TET2 HOXA13 KMT2C NCOA6 TOX ATRX EGFR MED12L AHR NCOA1 MAML2 KAT6B KLF4 SS18 RFX4 CREBBP MAML3 EP300 NPAS2 | 8.88e-09 | 1390 | 67 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TET2 KMT2C ARID1B RESF1 TOX ATRX BICRA KAT6A BANP AHR NCOA1 SMARCC2 ARID1A KAT6B SS18 CREBBP EP300 | 1.32e-08 | 999 | 67 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 KMT2C ARID1B RESF1 TOX ATRX BICRA KAT6A BANP NCOA1 SMARCC2 ARID1A KAT6B SS18 CREBBP EP300 | 1.97e-08 | 896 | 67 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 KMT2C ARID1B RESF1 ATRX BICRA KAT6A NCOA1 SMARCC2 ARID1A KAT6B SS18 CREBBP EP300 | 8.84e-08 | 741 | 67 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | head development | NCOA6 TOX ATRX EGFR ATXN2 USP9X KAT6A SEC24B NAV2 NCOA1 ARID1A RFX4 CREBBP EP300 TULP3 | 1.90e-07 | 919 | 67 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.26e-06 | 333 | 67 | 9 | GO:0051054 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 7.04e-06 | 143 | 67 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.17e-05 | 237 | 67 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.32e-05 | 564 | 67 | 10 | GO:0051052 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.34e-05 | 242 | 67 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.49e-05 | 246 | 67 | 7 | GO:1902806 | |
| GeneOntologyBiologicalProcess | brain development | NCOA6 TOX ATRX EGFR ATXN2 USP9X SEC24B NAV2 NCOA1 ARID1A RFX4 TULP3 | 1.83e-05 | 859 | 67 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | response to ketone | 1.83e-05 | 254 | 67 | 7 | GO:1901654 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ARID1B ATRX EGFR WDR33 USP9X NAF1 AHR BCCIP SMARCC2 ARID1A KLF4 CREBBP NPAS2 | 3.79e-05 | 1081 | 67 | 13 | GO:0006259 |
| GeneOntologyBiologicalProcess | DNA repair | ARID1B ATRX EGFR WDR33 USP9X BCCIP SMARCC2 ARID1A CREBBP NPAS2 | 4.31e-05 | 648 | 67 | 10 | GO:0006281 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 4.97e-05 | 202 | 67 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | DNA damage response | NCOA6 ARID1B ATRX EGFR WDR33 USP9X BCCIP SMARCC2 ARID1A CREBBP EP300 NPAS2 | 5.37e-05 | 959 | 67 | 12 | GO:0006974 |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 5.90e-05 | 416 | 67 | 8 | GO:0030522 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 5.93e-05 | 65 | 67 | 4 | GO:0045815 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 6.00e-05 | 306 | 67 | 7 | GO:0044843 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 6.21e-05 | 4 | 67 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 6.67e-05 | 213 | 67 | 6 | GO:2000045 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 7.08e-05 | 68 | 67 | 4 | GO:0141137 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 7.78e-05 | 135 | 67 | 5 | GO:0009791 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 8.05e-05 | 136 | 67 | 5 | GO:0045445 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 9.88e-05 | 142 | 67 | 5 | GO:0034728 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.04e-04 | 231 | 67 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 TOX ATRX EGFR ATXN2 USP9X SEC24B NAV2 NCOA1 ARID1A RFX4 TULP3 NPAS2 | 1.07e-04 | 1197 | 67 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.12e-04 | 234 | 67 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.12e-04 | 727 | 67 | 10 | GO:0032870 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.13e-04 | 29 | 67 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | TRERF1 TET2 HOXA13 EGFR AHR NCOA1 ARID1A KLF4 MN1 CREBBP TRIP4 EP300 | 1.25e-04 | 1048 | 67 | 12 | GO:0014070 |
| GeneOntologyBiologicalProcess | cellular response to heat | 1.40e-04 | 81 | 67 | 4 | GO:0034605 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.40e-04 | 153 | 67 | 5 | GO:0022037 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.41e-04 | 244 | 67 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA6 EGFR USP9X MBNL1 SEC24B NCOA1 ARID1A KLF4 EP300 GAB1 TULP3 | 1.49e-04 | 906 | 67 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | heart development | 1.56e-04 | 757 | 67 | 10 | GO:0007507 | |
| GeneOntologyBiologicalProcess | rhythmic process | 1.65e-04 | 360 | 67 | 7 | GO:0048511 | |
| GeneOntologyBiologicalProcess | embryo development | HOXA13 NCOA6 EGFR USP9X MBNL1 KAT6A SEC24B NCOA1 ARID1A KLF4 CREBBP EP300 GAB1 TULP3 | 1.77e-04 | 1437 | 67 | 14 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.83e-04 | 162 | 67 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA6 EGFR USP9X MBNL1 SEC24B NCOA1 ARID1A KLF4 EP300 GAB1 TULP3 | 1.86e-04 | 929 | 67 | 11 | GO:0009792 |
| GeneOntologyBiologicalProcess | neuron development | ARID1B SLITRK2 TOX EGFR ATXN2 USP9X NECTIN1 SEC24B SYN1 MAP3K13 KLF4 CREBBP EP300 EPHA8 | 2.13e-04 | 1463 | 67 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | post-embryonic hemopoiesis | 2.16e-04 | 7 | 67 | 2 | GO:0035166 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 2.16e-04 | 7 | 67 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | neuron projection development | ARID1B SLITRK2 TOX EGFR ATXN2 USP9X NECTIN1 SEC24B MAP3K13 KLF4 CREBBP EP300 EPHA8 | 2.17e-04 | 1285 | 67 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.25e-04 | 266 | 67 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 2.29e-04 | 92 | 67 | 4 | GO:0045661 | |
| GeneOntologyBiologicalProcess | response to lipid | TRERF1 HOXA13 TUT4 EGFR AHR NCOA1 TAB2 ARID1A KLF4 MN1 TRIP4 EP300 | 2.44e-04 | 1126 | 67 | 12 | GO:0033993 |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 2.48e-04 | 271 | 67 | 6 | GO:0000082 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 2.59e-04 | 95 | 67 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 3.20e-04 | 41 | 67 | 3 | GO:0060325 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.39e-04 | 185 | 67 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.39e-04 | 185 | 67 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 3.43e-04 | 42 | 67 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 3.47e-04 | 186 | 67 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | chromosome organization | 3.60e-04 | 686 | 67 | 9 | GO:0051276 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 3.94e-04 | 44 | 67 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HOXA13 SLITRK2 EGFR ATXN2 USP9X NECTIN1 SEC24B AHR MAP3K13 SS18 EP300 EPHA8 | 4.16e-04 | 1194 | 67 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | protein acylation | 4.23e-04 | 108 | 67 | 4 | GO:0043543 | |
| GeneOntologyBiologicalProcess | placenta development | 4.51e-04 | 197 | 67 | 5 | GO:0001890 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 4.53e-04 | 561 | 67 | 8 | GO:0048568 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 4.56e-04 | 426 | 67 | 7 | GO:0043010 | |
| GeneOntologyBiologicalProcess | response to hormone | TRERF1 NCOA6 ARID1B EGFR NCOA1 ARID1A MN1 TRIP4 EP300 GAB1 EPHA8 | 4.95e-04 | 1042 | 67 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | head morphogenesis | 5.10e-04 | 48 | 67 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | sensory organ development | 5.65e-04 | 730 | 67 | 9 | GO:0007423 | |
| GeneOntologyBiologicalProcess | hindbrain development | 5.78e-04 | 208 | 67 | 5 | GO:0030902 | |
| GeneOntologyBiologicalProcess | embryonic placenta development | 6.10e-04 | 119 | 67 | 4 | GO:0001892 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 6.10e-04 | 119 | 67 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 6.10e-04 | 51 | 67 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | response to heat | 6.49e-04 | 121 | 67 | 4 | GO:0009408 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 6.73e-04 | 748 | 67 | 9 | GO:0071396 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 6.90e-04 | 598 | 67 | 8 | GO:0080135 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 7.04e-04 | 330 | 67 | 6 | GO:0040029 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 7.22e-04 | 54 | 67 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 7.44e-04 | 605 | 67 | 8 | GO:0071407 | |
| GeneOntologyBiologicalProcess | limb development | 8.07e-04 | 224 | 67 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 8.07e-04 | 224 | 67 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 8.40e-04 | 226 | 67 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 8.49e-04 | 130 | 67 | 4 | GO:1901655 | |
| GeneOntologyBiologicalProcess | eye development | 9.22e-04 | 480 | 67 | 7 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 9.57e-04 | 483 | 67 | 7 | GO:0150063 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.00e-03 | 136 | 67 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | forebrain development | 1.03e-03 | 489 | 67 | 7 | GO:0030900 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.05e-03 | 491 | 67 | 7 | GO:0048880 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.08e-03 | 239 | 67 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | cerebellum development | 1.09e-03 | 139 | 67 | 4 | GO:0021549 | |
| GeneOntologyBiologicalProcess | face development | 1.13e-03 | 63 | 67 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.14e-03 | 242 | 67 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.14e-03 | 242 | 67 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | labyrinthine layer development | 1.18e-03 | 64 | 67 | 3 | GO:0060711 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 1.18e-03 | 64 | 67 | 3 | GO:0010171 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 1.21e-03 | 16 | 67 | 2 | GO:0061029 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.21e-03 | 16 | 67 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.21e-03 | 16 | 67 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoblast proliferation | 1.21e-03 | 16 | 67 | 2 | GO:0033689 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.24e-03 | 144 | 67 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.27e-03 | 248 | 67 | 5 | GO:0007623 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.29e-03 | 249 | 67 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.29e-03 | 249 | 67 | 5 | GO:0065004 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.31e-03 | 146 | 67 | 4 | GO:2000779 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.89e-08 | 30 | 67 | 5 | GO:0016514 | |
| GeneOntologyCellularComponent | npBAF complex | 9.42e-08 | 14 | 67 | 4 | GO:0071564 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 PPP1R8 KMT2C NCOA6 ARID1B WDR33 BICRA MED12L AHR BCCIP NCOA1 SMARCC2 ARID1A SS18 CREBBP TRIP4 NPAS2 | 1.08e-06 | 1377 | 67 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | bBAF complex | 3.72e-06 | 10 | 67 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | brahma complex | 1.12e-05 | 14 | 67 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | chromatin | HOXA13 ARID1B ATRX BICRA KAT6A AHR NCOA1 SMARCC2 ARID1A KAT6B KLF4 SS18 RFX4 CREBBP EP300 NPAS2 | 1.31e-05 | 1480 | 67 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.42e-05 | 96 | 67 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | nBAF complex | 1.71e-05 | 16 | 67 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | ATPase complex | 5.89e-05 | 129 | 67 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.15e-04 | 596 | 67 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 2.10e-04 | 7 | 67 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.37e-04 | 94 | 67 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 2.80e-04 | 8 | 67 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 3.48e-04 | 104 | 67 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 4.16e-04 | 109 | 67 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 6.54e-04 | 12 | 67 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | GBAF complex | 8.98e-04 | 14 | 67 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | nuclear body | 2.27e-03 | 903 | 67 | 9 | GO:0016604 | |
| HumanPheno | Thick eyebrow | 1.08e-06 | 154 | 28 | 8 | HP:0000574 | |
| HumanPheno | Hypospadias | HOXA13 ARID1B ATRX BICRA USP9X MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 2.15e-06 | 377 | 28 | 11 | HP:0000047 |
| HumanPheno | Hypoplastic fifth toenail | 2.68e-06 | 19 | 28 | 4 | HP:0011937 | |
| HumanPheno | Displacement of the urethral meatus | HOXA13 ARID1B ATRX BICRA USP9X MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 3.58e-06 | 397 | 28 | 11 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | HOXA13 ARID1B ATRX BICRA USP9X MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 3.76e-06 | 399 | 28 | 11 | HP:0032076 |
| HumanPheno | Long eyelashes | 4.31e-06 | 129 | 28 | 7 | HP:0000527 | |
| HumanPheno | Thin upper lip vermilion | ARID1B ATRX USP9X KAT6A MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 6.65e-06 | 339 | 28 | 10 | HP:0000219 |
| HumanPheno | Thin lips | ARID1B ATRX USP9X KAT6A MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 6.65e-06 | 339 | 28 | 10 | HP:0000213 |
| HumanPheno | Wide nasal base | 1.37e-05 | 28 | 28 | 4 | HP:0012810 | |
| HumanPheno | Abnormality of the urethra | HOXA13 ARID1B ATRX BICRA USP9X MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 1.66e-05 | 465 | 28 | 11 | HP:0000795 |
| HumanPheno | Abnormal nasal base norphology | 1.81e-05 | 30 | 28 | 4 | HP:0012808 | |
| HumanPheno | Autistic behavior | KMT2C ARID1B SLITRK2 ATRX BICRA USP9X KAT6A MED12L SYN1 SMARCC2 ARID1A CREBBP EP300 | 2.01e-05 | 678 | 28 | 13 | HP:0000729 |
| HumanPheno | Plantar crease between first and second toes | 2.91e-05 | 2 | 28 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.91e-05 | 2 | 28 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.91e-05 | 2 | 28 | 2 | HP:0001042 | |
| HumanPheno | Abnormality of dental eruption | 2.96e-05 | 240 | 28 | 8 | HP:0006292 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 3.17e-05 | 12 | 28 | 3 | HP:0010746 | |
| HumanPheno | Aggressive behavior | KMT2C ARID1B SLITRK2 ATRX USP9X MED12L SYN1 SMARCC2 ARID1A CREBBP EP300 | 4.47e-05 | 516 | 28 | 11 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | KMT2C ARID1B SLITRK2 ATRX USP9X MED12L SYN1 SMARCC2 ARID1A CREBBP EP300 | 4.47e-05 | 516 | 28 | 11 | HP:0006919 |
| HumanPheno | Abnormality of the upper respiratory tract | TET2 KMT2C ARID1B ATRX EGFR ATXN2 USP9X NECTIN1 KAT6A BAG3 SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 4.88e-05 | 1111 | 28 | 16 | HP:0002087 |
| HumanPheno | Hypoplastic fifth fingernail | 5.20e-05 | 14 | 28 | 3 | HP:0008398 | |
| HumanPheno | Congenital malformation of the great arteries | ARID1B BICRA USP9X KAT6A SMARCC2 TAB2 ARID1A KAT6B CREBBP TRIP4 EP300 | 5.64e-05 | 529 | 28 | 11 | HP:0011603 |
| HumanPheno | Thin vermilion border | ARID1B ATRX USP9X KAT6A MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 5.74e-05 | 433 | 28 | 10 | HP:0000233 |
| HumanPheno | Diagnostic behavioral phenotype | KMT2C ARID1B SLITRK2 ATRX BICRA USP9X KAT6A MED12L SYN1 SMARCC2 ARID1A CREBBP EP300 | 5.79e-05 | 747 | 28 | 13 | HP:0025783 |
| HumanPheno | Abnormal antihelix morphology | 7.78e-05 | 43 | 28 | 4 | HP:0009738 | |
| HumanPheno | Recurrent respiratory infections | TET2 ARID1B EGFR USP9X NECTIN1 KAT6A SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 8.50e-05 | 660 | 28 | 12 | HP:0002205 |
| HumanPheno | Laryngeal cartilage malformation | 8.71e-05 | 3 | 28 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 8.71e-05 | 3 | 28 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 8.71e-05 | 3 | 28 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 8.71e-05 | 3 | 28 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 8.71e-05 | 3 | 28 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 8.71e-05 | 3 | 28 | 2 | HP:0005895 | |
| HumanPheno | Neoplasm of the liver | 8.85e-05 | 140 | 28 | 6 | HP:0002896 | |
| HumanPheno | Recurrent infections | TET2 HOXA13 KMT2C ARID1B ATRX EGFR USP9X NECTIN1 KAT6A SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 9.11e-05 | 1030 | 28 | 15 | HP:0002719 |
| HumanPheno | Prominent eyelashes | 9.61e-05 | 17 | 28 | 3 | HP:0011231 | |
| HumanPheno | Oral aversion | 9.61e-05 | 17 | 28 | 3 | HP:0012523 | |
| HumanPheno | Deviation of the hallux | 9.86e-05 | 88 | 28 | 5 | HP:0010051 | |
| HumanPheno | Abnormal eyelash morphology | 9.87e-05 | 284 | 28 | 8 | HP:0000499 | |
| HumanPheno | Thin scalp hair | 9.97e-05 | 143 | 28 | 6 | HP:0002556 | |
| HumanPheno | Thin hair | 9.97e-05 | 143 | 28 | 6 | HP:0002237 | |
| HumanPheno | Abnormal scrotum morphology | 9.97e-05 | 143 | 28 | 6 | HP:0000045 | |
| HumanPheno | Sparse scalp hair | 9.97e-05 | 143 | 28 | 6 | HP:0002209 | |
| HumanPheno | Abnormal cardiac septum morphology | HOXA13 ARID1B ATRX BICRA USP9X KAT6A SMARCC2 TAB2 ARID1A KAT6B CREBBP TRIP4 EP300 | 1.01e-04 | 787 | 28 | 13 | HP:0001671 |
| HumanPheno | Prominent fingertip pads | 1.02e-04 | 46 | 28 | 4 | HP:0001212 | |
| HumanPheno | Abnormality of upper lip vermillion | ARID1B ATRX USP9X KAT6A MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 1.04e-04 | 464 | 28 | 10 | HP:0011339 |
| HumanPheno | Language impairment | KMT2C ARID1B SLITRK2 GALE ATXN2 USP9X NECTIN1 KAT6A MED12L SMARCC2 ARID1A KAT6B MN1 CREBBP TRIP4 EP300 | 1.04e-04 | 1178 | 28 | 16 | HP:0002463 |
| HumanPheno | Abnormal eyebrow morphology | KMT2C ARID1B EGFR BICRA NECTIN1 KAT6A MED12L SMARCC2 ARID1A MN1 CREBBP EP300 | 1.05e-04 | 674 | 28 | 12 | HP:0000534 |
| HumanPheno | Abnormal male external genitalia morphology | HOXA13 KMT2C ARID1B ATRX BICRA USP9X NAF1 NECTIN1 KAT6A MED12L AHR SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 1.12e-04 | 1329 | 28 | 17 | HP:0000032 |
| HumanPheno | Abnormality of hair texture | 1.14e-04 | 290 | 28 | 8 | HP:0010719 | |
| HumanPheno | Low anterior hairline | 1.16e-04 | 147 | 28 | 6 | HP:0000294 | |
| HumanPheno | Prominent digit pad | 1.20e-04 | 48 | 28 | 4 | HP:0011298 | |
| HumanPheno | Patent ductus arteriosus | 1.31e-04 | 382 | 28 | 9 | HP:0001643 | |
| HumanPheno | Cutaneous syndactyly of toes | 1.41e-04 | 50 | 28 | 4 | HP:0010621 | |
| HumanPheno | Abnormal nasal tip morphology | 1.41e-04 | 386 | 28 | 9 | HP:0000436 | |
| HumanPheno | Abnormality of the lower urinary tract | HOXA13 KMT2C ARID1B ATRX ATXN2 BICRA USP9X KAT6A MED12L SMARCC2 ARID1A KAT6B CREBBP EP300 | 1.42e-04 | 937 | 28 | 14 | HP:0010936 |
| HumanPheno | Sandal gap | 1.49e-04 | 96 | 28 | 5 | HP:0001852 | |
| HumanPheno | Short phalanx of finger | 1.67e-04 | 306 | 28 | 8 | HP:0009803 | |
| HumanPheno | Abnormal external genitalia | HOXA13 KMT2C ARID1B ATRX BICRA USP9X NAF1 NECTIN1 KAT6A MED12L AHR SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 1.72e-04 | 1372 | 28 | 17 | HP:0000811 |
| HumanPheno | Trichiasis | 1.74e-04 | 4 | 28 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.74e-04 | 4 | 28 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.74e-04 | 4 | 28 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.74e-04 | 4 | 28 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.74e-04 | 4 | 28 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.74e-04 | 4 | 28 | 2 | HP:0031207 | |
| HumanPheno | Unusual infection | TET2 HOXA13 KMT2C ARID1B ATRX EGFR USP9X NECTIN1 KAT6A SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 1.76e-04 | 1088 | 28 | 15 | HP:0032101 |
| HumanPheno | Localized hirsutism | 1.85e-04 | 21 | 28 | 3 | HP:0009889 | |
| HumanPheno | Abnormal thought pattern | 2.01e-04 | 404 | 28 | 9 | HP:5200269 | |
| HumanPheno | Cutaneous syndactyly | 2.08e-04 | 103 | 28 | 5 | HP:0012725 | |
| HumanPheno | Depressed nasal bridge | ARID1B ATRX BICRA USP9X MED12L SMARCC2 ARID1A KAT6B MN1 CREBBP EP300 | 2.15e-04 | 612 | 28 | 11 | HP:0005280 |
| HumanPheno | Flattened nasal bridge | ARID1B ATRX BICRA USP9X MED12L SMARCC2 ARID1A KAT6B MN1 CREBBP EP300 | 2.15e-04 | 612 | 28 | 11 | HP:0000425 |
| HumanPheno | Low hanging columella | 2.20e-04 | 56 | 28 | 4 | HP:0009765 | |
| HumanPheno | Recurrent upper respiratory tract infections | 2.21e-04 | 237 | 28 | 7 | HP:0002788 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 2.23e-04 | 319 | 28 | 8 | HP:0009767 | |
| HumanPheno | Abnormality of the pharynx | 2.28e-04 | 320 | 28 | 8 | HP:0000600 | |
| HumanPheno | Ventricular septal defect | HOXA13 ARID1B ATRX KAT6A SMARCC2 TAB2 ARID1A KAT6B CREBBP EP300 | 2.30e-04 | 510 | 28 | 10 | HP:0001629 |
| HumanPheno | Abnormal morphology of the great vessels | ARID1B EGFR BICRA USP9X KAT6A SMARCC2 TAB2 ARID1A KAT6B CREBBP TRIP4 EP300 | 2.48e-04 | 736 | 28 | 12 | HP:0030962 |
| HumanPheno | Delayed speech and language development | KMT2C ARID1B SLITRK2 GALE USP9X NECTIN1 KAT6A MED12L SMARCC2 ARID1A KAT6B MN1 CREBBP TRIP4 EP300 | 2.56e-04 | 1123 | 28 | 15 | HP:0000750 |
| HumanPheno | Gastroesophageal reflux | KMT2C ATRX BICRA USP9X KAT6A MED12L KAT6B CREBBP TRIP4 EP300 | 2.57e-04 | 517 | 28 | 10 | HP:0002020 |
| HumanPheno | Abnormality of the incisor | 2.60e-04 | 108 | 28 | 5 | HP:0000676 | |
| HumanPheno | Abnormal stomach morphology | TET2 KMT2C ARID1B ATRX BICRA USP9X KAT6A MED12L KAT6B CREBBP TRIP4 EP300 | 2.68e-04 | 742 | 28 | 12 | HP:0002577 |
| HumanPheno | Abnormal patella morphology | 2.72e-04 | 109 | 28 | 5 | HP:0003045 | |
| HumanPheno | Abnormal ventricular septum morphology | HOXA13 ARID1B ATRX KAT6A SMARCC2 TAB2 ARID1A KAT6B CREBBP EP300 | 2.74e-04 | 521 | 28 | 10 | HP:0010438 |
| HumanPheno | Simple ear | 2.79e-04 | 24 | 28 | 3 | HP:0020206 | |
| HumanPheno | Papillary thyroid carcinoma | 2.79e-04 | 24 | 28 | 3 | HP:0002895 | |
| HumanPheno | Short first metatarsal | 2.88e-04 | 5 | 28 | 2 | HP:0010105 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.88e-04 | 5 | 28 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.88e-04 | 5 | 28 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.88e-04 | 5 | 28 | 2 | HP:0030421 | |
| HumanPheno | Abnormality of mouth size | 2.95e-04 | 425 | 28 | 9 | HP:0011337 | |
| HumanPheno | Hypertrichosis | 2.95e-04 | 425 | 28 | 9 | HP:0000998 | |
| HumanPheno | Abnormal nasopharynx morphology | 3.00e-04 | 249 | 28 | 7 | HP:0001739 | |
| HumanPheno | Shawl scrotum | 3.16e-04 | 25 | 28 | 3 | HP:0000049 | |
| HumanPheno | Abnormality of the male genitalia | HOXA13 KMT2C ARID1B ATRX BICRA USP9X NAF1 NECTIN1 KAT6A MED12L AHR SMARCC2 ARID1A KAT6B CREBBP TRIP4 EP300 | 3.18e-04 | 1437 | 28 | 17 | HP:0010461 |
| HumanPheno | Brachydactyly (hand) | 3.23e-04 | 430 | 28 | 9 | HP:0100667 | |
| HumanPheno | Abnormal incisor morphology | 3.27e-04 | 62 | 28 | 4 | HP:0011063 | |
| HumanPheno | Recurrent maladaptive behavior | TET2 KMT2C ARID1B SLITRK2 ATRX ATXN2 BICRA USP9X KAT6A MED12L SYN1 SMARCC2 ARID1A MN1 CREBBP EP300 | 3.37e-04 | 1293 | 28 | 16 | HP:5200241 |
| HumanPheno | Abnormality of the scalp hair | 3.40e-04 | 433 | 28 | 9 | HP:0100037 | |
| HumanPheno | Abnormal nasal septum morphology | 3.49e-04 | 115 | 28 | 5 | HP:0000419 | |
| HumanPheno | Perimembranous ventricular septal defect | 3.55e-04 | 26 | 28 | 3 | HP:0011682 | |
| HumanPheno | Short 5th finger | 3.70e-04 | 64 | 28 | 4 | HP:0009237 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | HOXA13 KMT2C NCOA6 ARID1B EGFR BICRA KAT6A SEC24B BAG3 SMARCC2 ARID1A KLF4 RFX4 MN1 CREBBP EP300 GAB1 TULP3 | 8.61e-07 | 1269 | 55 | 18 | MP:0011111 |
| MousePheno | lethality throughout fetal growth and development | HOXA13 NCOA6 EGFR BICRA KAT6A SEC24B CREBBP EP300 GAB1 TULP3 | 6.40e-06 | 435 | 55 | 10 | MP:0006208 |
| MousePheno | abnormal fluid regulation | HOXA13 NCOA6 ARID1B EGFR BICRA KAT6A BAG3 AHR ARID1A KLF4 EP300 GAB1 TULP3 | 1.39e-05 | 826 | 55 | 13 | MP:0001784 |
| MousePheno | abnormal nervous system development | NCOA6 ARID1B EGFR USP9X SEC24B SYN1 NCOA1 MAP3K13 ARID1A KAT6B SS18 RFX4 CREBBP EP300 TULP3 EPHA8 | 1.68e-05 | 1257 | 55 | 16 | MP:0003861 |
| MousePheno | open neural tube | 2.76e-05 | 226 | 55 | 7 | MP:0000929 | |
| MousePheno | small heart | 3.37e-05 | 321 | 55 | 8 | MP:0002188 | |
| MousePheno | ventricular hypoplasia | 4.23e-05 | 99 | 55 | 5 | MP:0000279 | |
| MousePheno | small prostate gland dorsolateral lobe | 4.55e-05 | 3 | 55 | 2 | MP:0009740 | |
| MousePheno | placental labyrinth hypoplasia | 6.27e-05 | 20 | 55 | 3 | MP:0001715 | |
| MousePheno | failure of eyelid fusion | 6.27e-05 | 20 | 55 | 3 | MP:0009264 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 7.23e-05 | 263 | 55 | 7 | MP:0011099 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | TET2 HOXA13 NCOA6 TUT4 EGFR AHR SMARCC2 TAB2 KAT6B MN1 CREBBP EP300 GAB1 TULP3 | 8.27e-05 | 1124 | 55 | 14 | MP:0011112 |
| MousePheno | perinatal lethality | TET2 KMT2C NCOA6 ARID1B EGFR KAT6A SMARCC2 ARID1A KLF4 RFX4 MN1 CREBBP EP300 TULP3 | 8.76e-05 | 1130 | 55 | 14 | MP:0002081 |
| MousePheno | abnormal epidermis stratum granulosum morphology | 1.62e-04 | 70 | 55 | 4 | MP:0001239 | |
| MousePheno | abnormal spongiotrophoblast size | 1.76e-04 | 28 | 55 | 3 | MP:0012097 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.86e-04 | 410 | 55 | 8 | MP:0011102 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.86e-04 | 410 | 55 | 8 | MP:0031660 | |
| MousePheno | abnormal eyelid fusion | 1.96e-04 | 29 | 55 | 3 | MP:0009263 | |
| MousePheno | thin ventricular wall | 2.04e-04 | 138 | 55 | 5 | MP:0000280 | |
| MousePheno | abnormal eyelid development | 2.40e-04 | 31 | 55 | 3 | MP:0009651 | |
| MousePheno | abnormal palate morphology | 2.48e-04 | 321 | 55 | 7 | MP:0003755 | |
| MousePheno | hindlimb oligodactyly | 3.15e-04 | 7 | 55 | 2 | MP:0014281 | |
| MousePheno | clinodactyly | 3.15e-04 | 7 | 55 | 2 | MP:0006253 | |
| MousePheno | abnormal blood circulation | EGFR BICRA KAT6A TAB2 ARID1A SS18 CREBBP EP300 GAB1 TULP3 NPAS2 | 3.80e-04 | 845 | 55 | 11 | MP:0002128 |
| MousePheno | oligodactyly | 4.76e-04 | 39 | 55 | 3 | MP:0000565 | |
| MousePheno | abnormal skin appearance | 4.87e-04 | 473 | 55 | 8 | MP:0009931 | |
| MousePheno | prenatal lethality, incomplete penetrance | 5.86e-04 | 747 | 55 | 10 | MP:0011101 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 6.19e-04 | 268 | 55 | 6 | MP:0011108 | |
| MousePheno | abnormal epidermal layer morphology | 6.56e-04 | 271 | 55 | 6 | MP:0001216 | |
| MousePheno | abnormal neural tube closure | 6.63e-04 | 378 | 55 | 7 | MP:0003720 | |
| MousePheno | abnormal vestibuloocular reflex | 6.70e-04 | 10 | 55 | 2 | MP:0004844 | |
| MousePheno | decreased liver weight | 6.85e-04 | 102 | 55 | 4 | MP:0003402 | |
| MousePheno | thin myocardium compact layer | 7.76e-04 | 46 | 55 | 3 | MP:0004057 | |
| MousePheno | petechiae | 8.17e-04 | 11 | 55 | 2 | MP:0008816 | |
| MousePheno | abnormal prostate gland dorsolateral lobe morphology | 8.17e-04 | 11 | 55 | 2 | MP:0009381 | |
| MousePheno | postnatal lethality | TET2 TUT4 EGFR BAG3 AHR SMARCC2 TAB2 KAT6B CREBBP EP300 GAB1 TULP3 | 8.58e-04 | 1084 | 55 | 12 | MP:0002082 |
| MousePheno | cleft palate | 9.18e-04 | 289 | 55 | 6 | MP:0000111 | |
| MousePheno | abnormal heart ventricle morphology | HOXA13 NCOA6 EGFR BICRA KAT6A SEC24B ARID1A CREBBP EP300 GAB1 | 9.30e-04 | 793 | 55 | 10 | MP:0005294 |
| MousePheno | pericardial effusion | 9.40e-04 | 111 | 55 | 4 | MP:0005312 | |
| MousePheno | oral cleft | 9.51e-04 | 291 | 55 | 6 | MP:0021164 | |
| MousePheno | abnormal placenta labyrinth morphology | 9.69e-04 | 194 | 55 | 5 | MP:0001716 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 9.72e-04 | 112 | 55 | 4 | MP:0004808 | |
| MousePheno | absent eyelids | 9.78e-04 | 12 | 55 | 2 | MP:0001341 | |
| MousePheno | decreased embryo size | 9.89e-04 | 659 | 55 | 9 | MP:0001698 | |
| MousePheno | abnormal heart ventricle wall morphology | 1.04e-03 | 296 | 55 | 6 | MP:0031532 | |
| MousePheno | hemorrhage | 1.04e-03 | 664 | 55 | 9 | MP:0001914 | |
| MousePheno | abnormal embryo size | PPP1R8 NCOA6 EGFR BICRA USP9X SEC24B SMARCC2 ARID1A CREBBP EP300 GAB1 | 1.07e-03 | 956 | 55 | 11 | MP:0001697 |
| MousePheno | abnormal prenatal body size | PPP1R8 NCOA6 EGFR BICRA USP9X KAT6A SEC24B SMARCC2 ARID1A CREBBP EP300 GAB1 | 1.11e-03 | 1116 | 55 | 12 | MP:0010866 |
| MousePheno | abnormal mouth morphology | 1.11e-03 | 670 | 55 | 9 | MP:0000452 | |
| MousePheno | decreased placental labyrinth size | 1.11e-03 | 52 | 55 | 3 | MP:0011521 | |
| MousePheno | abnormal head morphology | NCOA6 EGFR NECTIN1 KAT6A SEC24B KAT6B KLF4 MN1 CREBBP EP300 GAB1 TULP3 | 1.14e-03 | 1120 | 55 | 12 | MP:0000432 |
| MousePheno | abnormal craniofacial development | 1.32e-03 | 425 | 55 | 7 | MP:0003935 | |
| Domain | SUZ | 1.76e-07 | 4 | 67 | 3 | IPR024771 | |
| Domain | SUZ | 1.76e-07 | 4 | 67 | 3 | PS51673 | |
| Domain | Nuc_rcpt_coact | 8.76e-07 | 6 | 67 | 3 | IPR009110 | |
| Domain | R3H | 3.65e-06 | 9 | 67 | 3 | SM00393 | |
| Domain | R3H | 7.13e-06 | 11 | 67 | 3 | PS51061 | |
| Domain | R3H | 7.13e-06 | 11 | 67 | 3 | PF01424 | |
| Domain | - | 7.13e-06 | 11 | 67 | 3 | 3.30.1370.50 | |
| Domain | R3H_dom | 7.13e-06 | 11 | 67 | 3 | IPR001374 | |
| Domain | BAF250_C | 1.27e-05 | 2 | 67 | 2 | IPR033388 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.27e-05 | 2 | 67 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.27e-05 | 2 | 67 | 2 | PF08214 | |
| Domain | KIX | 1.27e-05 | 2 | 67 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.27e-05 | 2 | 67 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.27e-05 | 2 | 67 | 2 | IPR031162 | |
| Domain | DUF902 | 1.27e-05 | 2 | 67 | 2 | PF06001 | |
| Domain | - | 1.27e-05 | 2 | 67 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.27e-05 | 2 | 67 | 2 | IPR010303 | |
| Domain | - | 1.27e-05 | 2 | 67 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.27e-05 | 2 | 67 | 2 | PF09030 | |
| Domain | - | 1.27e-05 | 2 | 67 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.27e-05 | 2 | 67 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.27e-05 | 2 | 67 | 2 | PS50134 | |
| Domain | BAF250_C | 1.27e-05 | 2 | 67 | 2 | PF12031 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.27e-05 | 2 | 67 | 2 | IPR013178 | |
| Domain | BAF250/Osa | 1.27e-05 | 2 | 67 | 2 | IPR021906 | |
| Domain | KAT11 | 1.27e-05 | 2 | 67 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.27e-05 | 2 | 67 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.27e-05 | 2 | 67 | 2 | IPR003101 | |
| Domain | KIX | 1.27e-05 | 2 | 67 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.27e-05 | 2 | 67 | 2 | PS51727 | |
| Domain | Neuroggenic_mastermind-like_N | 3.79e-05 | 3 | 67 | 2 | IPR019082 | |
| Domain | SUZ | 3.79e-05 | 3 | 67 | 2 | PF12752 | |
| Domain | MamL-1 | 3.79e-05 | 3 | 67 | 2 | PF09596 | |
| Domain | MamL-1 | 3.79e-05 | 3 | 67 | 2 | SM01275 | |
| Domain | PAS | 9.59e-05 | 25 | 67 | 3 | PF00989 | |
| Domain | PAS_fold | 9.59e-05 | 25 | 67 | 3 | IPR013767 | |
| Domain | MOZ_SAS | 1.26e-04 | 5 | 67 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 1.26e-04 | 5 | 67 | 2 | IPR002717 | |
| Domain | MYST_HAT | 1.26e-04 | 5 | 67 | 2 | PS51726 | |
| Domain | PAS | 2.03e-04 | 32 | 67 | 3 | SM00091 | |
| Domain | PAS | 2.44e-04 | 34 | 67 | 3 | IPR000014 | |
| Domain | PAS | 2.44e-04 | 34 | 67 | 3 | PS50112 | |
| Domain | ZF_PHD_2 | 3.77e-04 | 95 | 67 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 3.92e-04 | 96 | 67 | 4 | PS01359 | |
| Domain | H15 | 9.64e-04 | 13 | 67 | 2 | SM00526 | |
| Domain | H15 | 9.64e-04 | 13 | 67 | 2 | PS51504 | |
| Domain | - | 1.11e-03 | 218 | 67 | 5 | 1.10.10.10 | |
| Domain | Histone_H1/H5_H15 | 1.12e-03 | 14 | 67 | 2 | IPR005818 | |
| Domain | - | 1.29e-03 | 15 | 67 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.29e-03 | 15 | 67 | 2 | SM00501 | |
| Domain | ARID_dom | 1.29e-03 | 15 | 67 | 2 | IPR001606 | |
| Domain | ARID | 1.29e-03 | 15 | 67 | 2 | PS51011 | |
| Domain | ARID | 1.29e-03 | 15 | 67 | 2 | PF01388 | |
| Domain | WHTH_DNA-bd_dom | 1.76e-03 | 242 | 67 | 5 | IPR011991 | |
| Domain | ZZ | 1.87e-03 | 18 | 67 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.87e-03 | 18 | 67 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.87e-03 | 18 | 67 | 2 | PS01357 | |
| Domain | Znf_FYVE_PHD | 1.92e-03 | 147 | 67 | 4 | IPR011011 | |
| Domain | Znf_ZZ | 2.08e-03 | 19 | 67 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.08e-03 | 19 | 67 | 2 | SM00291 | |
| Domain | PHD | 2.48e-03 | 75 | 67 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.87e-03 | 79 | 67 | 3 | IPR019787 | |
| Domain | PAS_fold_3 | 3.06e-03 | 23 | 67 | 2 | IPR013655 | |
| Domain | PAS_3 | 3.06e-03 | 23 | 67 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 3.33e-03 | 24 | 67 | 2 | IPR000700 | |
| Domain | DHHC | 3.61e-03 | 25 | 67 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 3.61e-03 | 25 | 67 | 2 | IPR001594 | |
| Domain | PAC | 3.90e-03 | 26 | 67 | 2 | IPR001610 | |
| Domain | Bromodomain_CS | 3.90e-03 | 26 | 67 | 2 | IPR018359 | |
| Domain | PAC | 3.90e-03 | 26 | 67 | 2 | SM00086 | |
| Domain | PAC | 3.90e-03 | 26 | 67 | 2 | PS50113 | |
| Domain | SANT_dom | 3.90e-03 | 26 | 67 | 2 | IPR017884 | |
| Domain | PHD | 4.02e-03 | 89 | 67 | 3 | SM00249 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.34e-09 | 65 | 49 | 7 | M39682 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.66e-08 | 24 | 49 | 5 | M13404 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.59e-08 | 29 | 49 | 5 | M48076 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.26e-07 | 14 | 49 | 4 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.27e-07 | 16 | 49 | 4 | M27121 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.40e-07 | 272 | 49 | 9 | M29619 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.80e-07 | 18 | 49 | 4 | M26942 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.99e-07 | 20 | 49 | 4 | M27881 | |
| Pathway | REACTOME_HEME_SIGNALING | 6.99e-07 | 49 | 49 | 5 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.99e-07 | 49 | 49 | 5 | M618 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.54e-06 | 25 | 49 | 4 | M27880 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 2.13e-06 | 27 | 49 | 4 | M26943 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.18e-06 | 8 | 49 | 3 | M22058 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.37e-06 | 254 | 49 | 8 | M27131 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 3.16e-06 | 118 | 49 | 6 | M27316 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.20e-06 | 70 | 49 | 5 | M938 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.66e-06 | 10 | 49 | 3 | MM15535 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 7.82e-06 | 37 | 49 | 4 | M27797 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.49e-06 | 12 | 49 | 3 | M27159 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.69e-06 | 39 | 49 | 4 | MM14604 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.03e-05 | 84 | 49 | 5 | M1008 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.31e-05 | 42 | 49 | 4 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.31e-05 | 42 | 49 | 4 | M17541 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KMT2C NCOA6 ARID1B TUT4 EGFR NCOA1 SMARCC2 MAML2 ARID1A KLF4 SS18 CREBBP MAML3 EP300 GAB1 EPHA8 | 1.53e-05 | 1432 | 49 | 16 | M509 |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.73e-05 | 45 | 49 | 4 | M39615 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.06e-05 | 47 | 49 | 4 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.24e-05 | 48 | 49 | 4 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.24e-05 | 48 | 49 | 4 | M611 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.59e-05 | 17 | 49 | 3 | M48025 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.10e-05 | 18 | 49 | 3 | MM14775 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.83e-05 | 110 | 49 | 5 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 3.86e-05 | 55 | 49 | 4 | M27001 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 4.76e-05 | 58 | 49 | 4 | M29616 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.80e-05 | 22 | 49 | 3 | MM1370 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 9.43e-05 | 69 | 49 | 4 | M46439 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.09e-04 | 137 | 49 | 5 | M48232 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.18e-04 | 73 | 49 | 4 | M638 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.18e-04 | 5 | 49 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.18e-04 | 5 | 49 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.18e-04 | 5 | 49 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.18e-04 | 5 | 49 | 2 | M27228 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.22e-04 | 28 | 49 | 3 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.24e-04 | 74 | 49 | 4 | M616 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.29e-04 | 142 | 49 | 5 | M27233 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.50e-04 | 30 | 49 | 3 | M207 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.62e-04 | 237 | 49 | 6 | M27786 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.66e-04 | 31 | 49 | 3 | M39522 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.76e-04 | 6 | 49 | 2 | M22062 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | KMT2C ARID1B EGFR WDR33 USP9X KAT6A BANP SMARCC2 MAML2 ARID1A KLF4 CREBBP MAML3 EP300 | 1.85e-04 | 1387 | 49 | 14 | M734 |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.85e-04 | 82 | 49 | 4 | MM15922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.85e-04 | 82 | 49 | 4 | M594 | |
| Pathway | PID_REG_GR_PATHWAY | 1.85e-04 | 82 | 49 | 4 | M115 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 2.00e-04 | 33 | 49 | 3 | M604 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.19e-04 | 34 | 49 | 3 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.39e-04 | 35 | 49 | 3 | M47969 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.46e-04 | 7 | 49 | 2 | MM1573 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.76e-04 | 91 | 49 | 4 | M39700 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.06e-04 | 38 | 49 | 3 | M27757 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.25e-04 | 95 | 49 | 4 | M48268 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.27e-04 | 8 | 49 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.27e-04 | 8 | 49 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.27e-04 | 8 | 49 | 2 | M46443 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 3.38e-04 | 96 | 49 | 4 | M27784 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.41e-04 | 175 | 49 | 5 | MM14941 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 3.52e-04 | 97 | 49 | 4 | M48262 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 3.95e-04 | 100 | 49 | 4 | MM15826 | |
| Pathway | PID_TCPTP_PATHWAY | 4.12e-04 | 42 | 49 | 3 | M91 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 4.12e-04 | 42 | 49 | 3 | M27172 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47451 | |
| Pathway | WP_IL6_SIGNALING | 4.42e-04 | 43 | 49 | 3 | M39656 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 4.73e-04 | 44 | 49 | 3 | M27295 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.23e-04 | 10 | 49 | 2 | M27945 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 5.39e-04 | 46 | 49 | 3 | MM14935 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | 5.39e-04 | 46 | 49 | 3 | M39661 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 5.67e-04 | 110 | 49 | 4 | M48043 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 5.82e-04 | 301 | 49 | 6 | MM15983 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.38e-04 | 11 | 49 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.38e-04 | 11 | 49 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.38e-04 | 11 | 49 | 2 | M26924 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 6.50e-04 | 49 | 49 | 3 | MM14695 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 7.63e-04 | 119 | 49 | 4 | M607 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.64e-04 | 12 | 49 | 2 | M27765 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.64e-04 | 12 | 49 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 7.64e-04 | 12 | 49 | 2 | M47533 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M22006 | |
| Pathway | PID_KIT_PATHWAY | 7.74e-04 | 52 | 49 | 3 | M231 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 7.74e-04 | 52 | 49 | 3 | M2404 | |
| Pathway | PID_AR_TF_PATHWAY | 8.18e-04 | 53 | 49 | 3 | M151 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 8.18e-04 | 53 | 49 | 3 | M27039 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 8.37e-04 | 122 | 49 | 4 | M29689 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 9.01e-04 | 13 | 49 | 2 | M47534 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 9.01e-04 | 13 | 49 | 2 | MM15622 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 9.12e-04 | 55 | 49 | 3 | M27145 | |
| Pathway | REACTOME_GASTRULATION | 1.03e-03 | 129 | 49 | 4 | M46433 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.05e-03 | 14 | 49 | 2 | MM14761 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.18e-03 | 60 | 49 | 3 | M41830 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.21e-03 | 15 | 49 | 2 | MM1339 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 1.21e-03 | 15 | 49 | 2 | M29701 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M10183 | |
| Pubmed | TRERF1 TET2 KMT2C NCOA6 ARID1B RESF1 ATRX ATXN2 WDR33 BICRA USP9X MBNL1 SEC24B BANP NCOA1 SMARCC2 R3HDM2 SCAF11 R3HDM1 ARID1A KLF4 SS18 CREBBP GARRE1 EP300 | 8.67e-18 | 1429 | 68 | 25 | 35140242 | |
| Pubmed | TET2 RESF1 WDR33 BICRA FAM222B NCOA1 R3HDM2 R3HDM1 CREBBP GARRE1 EP300 | 9.53e-15 | 152 | 68 | 11 | 38360978 | |
| Pubmed | NCOA6 ARID1B ATRX KAT6A SMARCC2 ARID1A KAT6B SS18 CREBBP EP300 | 6.11e-13 | 157 | 68 | 10 | 30186101 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 TET2 KMT2C NCOA6 ARID1B RESF1 BICRA NCOA1 SMARCC2 ARID1A CREBBP EP300 | 4.06e-12 | 351 | 68 | 12 | 38297188 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EP400P1 KMT2C CFAP20DC TUT4 ATRX EGFR ATXN2 BICRA MBNL1 KAT6A BANP SCAF11 ARID1A KAT6B CREBBP MAML3 EP300 TULP3 NPAS2 SGK2 | 4.34e-12 | 1489 | 68 | 20 | 28611215 |
| Pubmed | EP400P1 ARID1B TUT4 RESF1 BICRA NAF1 GRAP2 KAT6A AHR SMARCC2 ARID1A KAT6B SS18 CREBBP TRIP4 GARRE1 EP300 | 3.46e-11 | 1116 | 68 | 17 | 31753913 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | KMT2C NCOA6 ARID1B ATXN2 WDR33 FAM222B MBNL1 BCCIP ARID1A CREBBP MAML3 EP300 | 8.60e-11 | 457 | 68 | 12 | 32344865 |
| Pubmed | TRERF1 TET2 NCOA6 ARID1B WDR33 NCOA1 SMARCC2 ARID1A KLF4 CREBBP | 1.22e-10 | 268 | 68 | 10 | 33640491 | |
| Pubmed | 4.88e-10 | 21 | 68 | 5 | 19596656 | ||
| Pubmed | 1.50e-09 | 57 | 68 | 6 | 18022353 | ||
| Pubmed | 1.92e-09 | 27 | 68 | 5 | 29374058 | ||
| Pubmed | 2.27e-09 | 61 | 68 | 6 | 20305087 | ||
| Pubmed | TRERF1 TET2 HOXA13 KMT2C NCOA6 ARID1B RESF1 ATXN2 BICRA MBNL1 NCOA1 SMARCC2 ARID1A CREBBP EP300 | 2.77e-09 | 1103 | 68 | 15 | 34189442 | |
| Pubmed | NCOA6 ARID1B USP9X NCOA1 SMARCC2 TAB2 ARID1A SS18 CREBBP MAML3 EP300 RASAL2 | 3.74e-09 | 638 | 68 | 12 | 31182584 | |
| Pubmed | 4.36e-09 | 11 | 68 | 4 | 10454579 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 KMT2C ARID1B RESF1 BICRA NCOA1 SMARCC2 ARID1A CREBBP EP300 | 5.54e-09 | 398 | 68 | 10 | 35016035 |
| Pubmed | 6.54e-09 | 12 | 68 | 4 | 12189208 | ||
| Pubmed | 6.54e-09 | 12 | 68 | 4 | 11734557 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 11349124 | ||
| Pubmed | 1.32e-08 | 14 | 68 | 4 | 12482968 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.53e-08 | 40 | 68 | 5 | 34585037 | |
| Pubmed | 1.79e-08 | 15 | 68 | 4 | 23785148 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 12208951 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 11463834 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 11113179 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 21482710 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 28398509 | ||
| Pubmed | 6.32e-08 | 20 | 68 | 4 | 11877444 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 14722092 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 17908689 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 17182677 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 11912212 | ||
| Pubmed | TET2 KMT2C NCOA6 ARID1B MED12L NAV2 SCAF11 MAML2 KAT6B GARRE1 | 8.04e-08 | 529 | 68 | 10 | 14621295 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 NCOA6 RESF1 SEC24B BAG3 NAV2 TAB2 PTPN21 R3HDM1 GARRE1 GAB1 RASAL2 | 1.00e-07 | 861 | 68 | 12 | 36931259 |
| Pubmed | PPP1R8 ARID1B EGFR ATXN2 USP9X SEC24B BAG3 TAB2 STAM PTPN21 ARID1A GAB1 TULP3 | 1.07e-07 | 1049 | 68 | 13 | 27880917 | |
| Pubmed | KMT2C NCOA6 ARID1B WDR33 USP9X SEC24B BAG3 ARID1A CREBBP EP300 | 1.13e-07 | 549 | 68 | 10 | 38280479 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.15e-07 | 23 | 68 | 4 | 30962207 | |
| Pubmed | HOXA13 KMT2C TOX MBNL1 AHR NCOA1 ARID1A KAT6B KLF4 CREBBP MAML3 | 1.25e-07 | 709 | 68 | 11 | 22988430 | |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 1.42e-07 | 6 | 68 | 3 | 11076796 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 10497212 | ||
| Pubmed | Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | 1.42e-07 | 6 | 68 | 3 | 15961999 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 10913131 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 16230384 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 1.42e-07 | 6 | 68 | 3 | 15615775 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 10973497 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.13e-07 | 588 | 68 | 10 | 38580884 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 23540691 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.49e-07 | 7 | 68 | 3 | 9590696 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.57e-07 | 220 | 68 | 7 | 35785414 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HOXA13 NCOA6 ARID1B ATRX ATXN2 WDR33 BICRA MBNL1 SMARCC2 SCAF11 ARID1A SS18 | 3.01e-07 | 954 | 68 | 12 | 36373674 |
| Pubmed | 3.06e-07 | 29 | 68 | 4 | 19279220 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 26109068 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 17475621 | ||
| Pubmed | 4.24e-07 | 634 | 68 | 10 | 34591612 | ||
| Pubmed | 4.65e-07 | 78 | 68 | 5 | 28611094 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 23556151 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 37805104 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 5.95e-07 | 9 | 68 | 3 | 20086098 | |
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 12665591 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 8.49e-07 | 10 | 68 | 3 | 16751102 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 8.49e-07 | 10 | 68 | 3 | 30595551 | |
| Pubmed | 8.54e-07 | 263 | 68 | 7 | 34702444 | ||
| Pubmed | Acetylation of HIV-1 integrase by p300 regulates viral integration. | 1.17e-06 | 11 | 68 | 3 | 16096645 | |
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 1.17e-06 | 11 | 68 | 3 | 15681609 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 18003620 | ||
| Pubmed | 1.52e-06 | 730 | 68 | 10 | 34857952 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.55e-06 | 12 | 68 | 3 | 14645221 | |
| Pubmed | Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. | 1.55e-06 | 12 | 68 | 3 | 25219498 | |
| Pubmed | 1.63e-06 | 183 | 68 | 6 | 36129980 | ||
| Pubmed | 1.81e-06 | 425 | 68 | 8 | 24999758 | ||
| Pubmed | 2.02e-06 | 13 | 68 | 3 | 17340523 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.55e-06 | 774 | 68 | 10 | 15302935 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 2.56e-06 | 14 | 68 | 3 | 36289231 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 2.56e-06 | 14 | 68 | 3 | 11500849 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 2.56e-06 | 14 | 68 | 3 | 17641689 | |
| Pubmed | 2.59e-06 | 446 | 68 | 8 | 24255178 | ||
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 2.88e-06 | 50 | 68 | 4 | 27716508 | |
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 3.20e-06 | 15 | 68 | 3 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 3.20e-06 | 15 | 68 | 3 | 17920018 | |
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 10567404 | ||
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 11263494 | ||
| Pubmed | 3.73e-06 | 808 | 68 | 10 | 20412781 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27881875 | ||
| Pubmed | New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. | 3.77e-06 | 2 | 68 | 2 | 17296583 | |
| Pubmed | PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells. | 3.77e-06 | 2 | 68 | 2 | 20923765 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 3.77e-06 | 2 | 68 | 2 | 34845315 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19729597 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 39287984 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25217982 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31465134 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20717166 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25893291 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11559821 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26880370 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32576962 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19822209 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 3.77e-06 | 2 | 68 | 2 | 21847097 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 3.77e-06 | 2 | 68 | 2 | 37611161 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32791957 | ||
| Interaction | ERG interactions | TET2 KMT2C NCOA6 ARID1B RESF1 BICRA USP9X SYN1 SMARCC2 ARID1A SS18 CREBBP EP300 | 4.81e-13 | 223 | 68 | 13 | int:ERG |
| Interaction | SP7 interactions | TRERF1 TET2 KMT2C NCOA6 ARID1B WDR33 BICRA MBNL1 NCOA1 SMARCC2 ARID1A SS18 CREBBP EP300 | 1.39e-12 | 304 | 68 | 14 | int:SP7 |
| Interaction | EYA4 interactions | TET2 RESF1 WDR33 BICRA FAM222B SEC24B BAG3 NCOA1 R3HDM2 R3HDM1 CREBBP GARRE1 EP300 | 1.44e-12 | 243 | 68 | 13 | int:EYA4 |
| Interaction | SOX7 interactions | 7.90e-12 | 82 | 68 | 9 | int:SOX7 | |
| Interaction | EGR2 interactions | TRERF1 TET2 KMT2C NCOA6 ARID1B RESF1 BICRA NCOA1 ARID1A CREBBP EP300 | 1.20e-11 | 171 | 68 | 11 | int:EGR2 |
| Interaction | SS18L1 interactions | 4.06e-11 | 98 | 68 | 9 | int:SS18L1 | |
| Interaction | AR interactions | TRERF1 TET2 HOXA13 KMT2C NCOA6 ARID1B ATRX EGFR WDR33 GRAP2 MED12L AHR NCOA1 SMARCC2 TAB2 ARID1A KLF4 CREBBP TRIP4 EP300 | 5.00e-11 | 992 | 68 | 20 | int:AR |
| Interaction | GCM1 interactions | 6.92e-11 | 68 | 68 | 8 | int:GCM1 | |
| Interaction | ALG13 interactions | ARID1B EGFR ATXN2 WDR33 R3HDM2 R3HDM1 ARID1A GARRE1 EP300 TULP3 | 5.49e-10 | 183 | 68 | 10 | int:ALG13 |
| Interaction | CRX interactions | TRERF1 TET2 KMT2C ARID1B BICRA BANP NCOA1 ARID1A CREBBP EP300 NPAS2 | 8.35e-10 | 254 | 68 | 11 | int:CRX |
| Interaction | CREBBP interactions | TRERF1 PPP1R8 NCOA6 ARID1B ATRX KAT6A NCOA1 SMARCC2 MAML2 ARID1A KLF4 CREBBP TRIP4 EP300 NPAS2 | 1.09e-09 | 599 | 68 | 15 | int:CREBBP |
| Interaction | HNF4A interactions | KMT2C NCOA6 ARID1B ATRX BICRA NCOA1 SMARCC2 ARID1A SS18 CREBBP EP300 | 1.93e-09 | 275 | 68 | 11 | int:HNF4A |
| Interaction | EP300 interactions | TRERF1 NCOA6 EGFR USP9X KAT6A SEC24B BANP AHR BCCIP NCOA1 SMARCC2 MAML2 ARID1A KLF4 SS18 MN1 CREBBP TRIP4 EP300 TULP3 NPAS2 | 3.30e-09 | 1401 | 68 | 21 | int:EP300 |
| Interaction | TBXT interactions | 5.23e-09 | 116 | 68 | 8 | int:TBXT | |
| Interaction | R3HDM2 interactions | 1.21e-08 | 129 | 68 | 8 | int:R3HDM2 | |
| Interaction | PAX9 interactions | 1.29e-08 | 130 | 68 | 8 | int:PAX9 | |
| Interaction | DPF1 interactions | 3.17e-08 | 95 | 68 | 7 | int:DPF1 | |
| Interaction | SOX9 interactions | 3.67e-08 | 97 | 68 | 7 | int:SOX9 | |
| Interaction | SMARCA4 interactions | ARID1B EGFR BICRA KAT6A AHR NCOA1 SMARCC2 ARID1A KLF4 SS18 CREBBP EP300 | 4.16e-08 | 462 | 68 | 12 | int:SMARCA4 |
| Interaction | PPARG interactions | 7.74e-08 | 307 | 68 | 10 | int:PPARG | |
| Interaction | FOS interactions | KMT2C NCOA6 ARID1B EGFR NCOA1 SMARCC2 ARID1A SS18 CREBBP EP300 | 9.00e-08 | 312 | 68 | 10 | int:FOS |
| Interaction | SMG7 interactions | NCOA6 ARID1B EGFR ATXN2 NCOA1 R3HDM2 R3HDM1 ARID1A CREBBP GARRE1 | 1.11e-07 | 319 | 68 | 10 | int:SMG7 |
| Interaction | BRD9 interactions | 1.34e-07 | 117 | 68 | 7 | int:BRD9 | |
| Interaction | NUP35 interactions | KMT2C NCOA6 ARID1B ATXN2 WDR33 FAM222B MBNL1 ARID1A CREBBP MAML3 EP300 | 1.64e-07 | 424 | 68 | 11 | int:NUP35 |
| Interaction | ETS1 interactions | 1.69e-07 | 121 | 68 | 7 | int:ETS1 | |
| Interaction | DBR1 interactions | 2.26e-07 | 40 | 68 | 5 | int:DBR1 | |
| Interaction | SMAP2 interactions | 2.36e-07 | 189 | 68 | 8 | int:SMAP2 | |
| Interaction | SMAD3 interactions | NCOA6 ARID1B USP9X KAT6A BAG3 NCOA1 SMARCC2 ARID1A CREBBP TRIP4 EP300 | 2.78e-07 | 447 | 68 | 11 | int:SMAD3 |
| Interaction | MYOD1 interactions | 2.88e-07 | 194 | 68 | 8 | int:MYOD1 | |
| Interaction | KLF5 interactions | 2.99e-07 | 195 | 68 | 8 | int:KLF5 | |
| Interaction | GATA2 interactions | 3.50e-07 | 199 | 68 | 8 | int:GATA2 | |
| Interaction | ARID1A interactions | 3.62e-07 | 276 | 68 | 9 | int:ARID1A | |
| Interaction | FEV interactions | 4.07e-07 | 203 | 68 | 8 | int:FEV | |
| Interaction | TLE3 interactions | TRERF1 TET2 ARID1B MBNL1 NCOA1 SMARCC2 STAM ARID1A CREBBP EP300 | 5.04e-07 | 376 | 68 | 10 | int:TLE3 |
| Interaction | SS18 interactions | 5.14e-07 | 88 | 68 | 6 | int:SS18 | |
| Interaction | NCOA1 interactions | 6.07e-07 | 146 | 68 | 7 | int:NCOA1 | |
| Interaction | MKRN2 interactions | ATRX EGFR ATXN2 R3HDM2 R3HDM1 TRIP4 GARRE1 EP300 TULP3 EPHA8 | 6.25e-07 | 385 | 68 | 10 | int:MKRN2 |
| Interaction | DPF3 interactions | 8.09e-07 | 95 | 68 | 6 | int:DPF3 | |
| Interaction | NCOA3 interactions | 8.57e-07 | 224 | 68 | 8 | int:NCOA3 | |
| Interaction | KLF4 interactions | 1.13e-06 | 160 | 68 | 7 | int:KLF4 | |
| Interaction | TPRX2 interactions | 1.26e-06 | 56 | 68 | 5 | int:TPRX2 | |
| Interaction | PAX8 interactions | 2.02e-06 | 111 | 68 | 6 | int:PAX8 | |
| Interaction | FLI1 interactions | 2.10e-06 | 62 | 68 | 5 | int:FLI1 | |
| Interaction | TEAD1 interactions | 2.13e-06 | 176 | 68 | 7 | int:TEAD1 | |
| Interaction | ARID1B interactions | 2.21e-06 | 177 | 68 | 7 | int:ARID1B | |
| Interaction | YAP1 interactions | TRERF1 HOXA13 KMT2C NCOA6 ARID1B EGFR WDR33 USP9X BAG3 SMARCC2 PTPN21 ARID1A CREBBP EP300 GAB1 | 2.83e-06 | 1095 | 68 | 15 | int:YAP1 |
| Interaction | YWHAH interactions | TET2 NCOA6 RESF1 SEC24B BAG3 NAV2 NCOA1 TAB2 R3HDM2 PTPN21 R3HDM1 CREBBP GARRE1 GAB1 RASAL2 | 3.06e-06 | 1102 | 68 | 15 | int:YWHAH |
| Interaction | BICRA interactions | 3.09e-06 | 67 | 68 | 5 | int:BICRA | |
| Interaction | YWHAE interactions | TET2 NAF1 GRAP2 BAG3 NAV2 SYN1 BCCIP SMARCC2 TAB2 R3HDM2 SCAF11 PTPN21 R3HDM1 GARRE1 GAB1 RASAL2 | 3.17e-06 | 1256 | 68 | 16 | int:YWHAE |
| Interaction | DDIT3 interactions | 3.18e-06 | 120 | 68 | 6 | int:DDIT3 | |
| Interaction | HNF1B interactions | 3.54e-06 | 190 | 68 | 7 | int:HNF1B | |
| Interaction | SMARCB1 interactions | 3.57e-06 | 364 | 68 | 9 | int:SMARCB1 | |
| Interaction | ETV4 interactions | 3.58e-06 | 69 | 68 | 5 | int:ETV4 | |
| Interaction | BCL7A interactions | 3.67e-06 | 123 | 68 | 6 | int:BCL7A | |
| Interaction | NR3C1 interactions | NCOA6 ARID1B EGFR USP9X NCOA1 SMARCC2 TAB2 ARID1A SS18 CREBBP C1orf94 MAML3 EP300 RASAL2 | 3.71e-06 | 974 | 68 | 14 | int:NR3C1 |
| Interaction | PAX6 interactions | 3.73e-06 | 366 | 68 | 9 | int:PAX6 | |
| Interaction | PAX7 interactions | 3.85e-06 | 124 | 68 | 6 | int:PAX7 | |
| Interaction | ASCC1 interactions | 4.13e-06 | 71 | 68 | 5 | int:ASCC1 | |
| Interaction | RUNX2 interactions | 4.22e-06 | 126 | 68 | 6 | int:RUNX2 | |
| Interaction | ANKS1B interactions | 5.09e-06 | 34 | 68 | 4 | int:ANKS1B | |
| Interaction | SMAD2 interactions | 5.63e-06 | 385 | 68 | 9 | int:SMAD2 | |
| Interaction | SS18L2 interactions | 5.78e-06 | 76 | 68 | 5 | int:SS18L2 | |
| Interaction | YWHAZ interactions | TET2 EGFR KAT6A BAG3 NAV2 SYN1 TAB2 R3HDM2 SCAF11 PTPN21 R3HDM1 ARID1A GARRE1 EP300 GAB1 RASAL2 | 5.93e-06 | 1319 | 68 | 16 | int:YWHAZ |
| Interaction | MED1 interactions | 6.02e-06 | 206 | 68 | 7 | int:MED1 | |
| Interaction | HOXB2 interactions | 6.44e-06 | 36 | 68 | 4 | int:HOXB2 | |
| Interaction | E2F5 interactions | 6.44e-06 | 36 | 68 | 4 | int:E2F5 | |
| Interaction | ING4 interactions | 6.57e-06 | 78 | 68 | 5 | int:ING4 | |
| Interaction | MAGED1 interactions | 6.62e-06 | 295 | 68 | 8 | int:MAGED1 | |
| Interaction | BAG2 interactions | NCOA6 TUT4 EGFR MBNL1 BAG3 TAB2 STAM R3HDM1 CREBBP EP300 RASAL2 | 6.88e-06 | 622 | 68 | 11 | int:BAG2 |
| Interaction | KLF1 interactions | 7.20e-06 | 37 | 68 | 4 | int:KLF1 | |
| Interaction | PPARGC1A interactions | 8.40e-06 | 82 | 68 | 5 | int:PPARGC1A | |
| Interaction | FAM168A interactions | 8.41e-06 | 142 | 68 | 6 | int:FAM168A | |
| Interaction | IRF1 interactions | 8.92e-06 | 83 | 68 | 5 | int:IRF1 | |
| Interaction | SUPT5H interactions | 8.97e-06 | 408 | 68 | 9 | int:SUPT5H | |
| Interaction | DAZL interactions | 9.48e-06 | 145 | 68 | 6 | int:DAZL | |
| Interaction | MEX3B interactions | 9.81e-06 | 222 | 68 | 7 | int:MEX3B | |
| Interaction | IRF4 interactions | 1.00e-05 | 85 | 68 | 5 | int:IRF4 | |
| Interaction | RARA interactions | 1.01e-05 | 223 | 68 | 7 | int:RARA | |
| Interaction | ASCL2 interactions | 1.03e-05 | 13 | 68 | 3 | int:ASCL2 | |
| Interaction | SRC interactions | NCOA6 EGFR ATXN2 AHR SYN1 BCCIP PTPN21 ARID1A CREBBP EP300 GAB1 | 1.27e-05 | 664 | 68 | 11 | int:SRC |
| Interaction | RUNX1 interactions | 1.31e-05 | 324 | 68 | 8 | int:RUNX1 | |
| Interaction | TEC interactions | 1.33e-05 | 90 | 68 | 5 | int:TEC | |
| Interaction | CEBPA interactions | TRERF1 TET2 HOXA13 KMT2C NCOA6 ARID1B RESF1 ATXN2 BICRA MBNL1 NCOA1 SMARCC2 ARID1A CREBBP EP300 | 1.34e-05 | 1245 | 68 | 15 | int:CEBPA |
| Interaction | CARM1 interactions | 1.34e-05 | 325 | 68 | 8 | int:CARM1 | |
| Interaction | FOXI1 interactions | 1.48e-05 | 92 | 68 | 5 | int:FOXI1 | |
| Interaction | SOX2 interactions | TRERF1 TET2 KMT2C NCOA6 ARID1B GALE EGFR USP9X BAG3 NAV2 SMARCC2 MAP3K13 ARID1A KAT6B SS18 EP300 | 1.53e-05 | 1422 | 68 | 16 | int:SOX2 |
| Interaction | SEC24B interactions | 1.63e-05 | 240 | 68 | 7 | int:SEC24B | |
| Interaction | SOX17 interactions | 1.73e-05 | 95 | 68 | 5 | int:SOX17 | |
| Interaction | SMAD1 interactions | 1.76e-05 | 243 | 68 | 7 | int:SMAD1 | |
| Interaction | ANAPC7 interactions | 1.78e-05 | 162 | 68 | 6 | int:ANAPC7 | |
| Interaction | ASF1A interactions | 2.06e-05 | 249 | 68 | 7 | int:ASF1A | |
| Interaction | SMARCA2 interactions | 2.10e-05 | 346 | 68 | 8 | int:SMARCA2 | |
| Interaction | FOSB interactions | 2.24e-05 | 49 | 68 | 4 | int:FOSB | |
| Interaction | RXRA interactions | 2.27e-05 | 169 | 68 | 6 | int:RXRA | |
| Interaction | TBP interactions | 2.28e-05 | 253 | 68 | 7 | int:TBP | |
| Interaction | MAML2 interactions | 2.42e-05 | 17 | 68 | 3 | int:MAML2 | |
| Interaction | GATA1 interactions | 2.42e-05 | 171 | 68 | 6 | int:GATA1 | |
| Interaction | SMARCC2 interactions | 2.42e-05 | 353 | 68 | 8 | int:SMARCC2 | |
| Interaction | ING1 interactions | 2.55e-05 | 103 | 68 | 5 | int:ING1 | |
| Interaction | ITCH interactions | 2.57e-05 | 356 | 68 | 8 | int:ITCH | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.62e-10 | 17 | 43 | 5 | 486 | |
| GeneFamily | AT-rich interaction domain containing | 5.69e-04 | 15 | 43 | 2 | 418 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 6.49e-04 | 16 | 43 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.25e-04 | 18 | 43 | 2 | 91 | |
| GeneFamily | PHD finger proteins | 1.27e-03 | 90 | 43 | 3 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.60e-03 | 25 | 43 | 2 | 775 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.27e-03 | 110 | 43 | 3 | 420 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 7.05e-03 | 53 | 43 | 2 | 532 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 7.05e-03 | 53 | 43 | 2 | 103 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TUT4 ATRX EGFR ATXN2 USP9X MBNL1 KAT6A SEC24B NCOA1 TAB2 R3HDM2 STAM R3HDM1 KAT6B CREBBP | 8.40e-13 | 466 | 68 | 15 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TUT4 ATRX EGFR ATXN2 USP9X MBNL1 KAT6A SEC24B NCOA1 TAB2 R3HDM2 STAM R3HDM1 KAT6B MN1 CREBBP GARRE1 | 4.41e-11 | 856 | 68 | 17 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.20e-08 | 180 | 68 | 8 | M8239 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 KMT2C TUT4 RESF1 TOX ATRX USP9X MBNL1 GRAP2 KAT6A AHR NCOA1 TAB2 SCAF11 ARID1A KAT6B CREBBP EP300 | 2.97e-08 | 1492 | 68 | 18 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 8.16e-08 | 300 | 68 | 9 | M8702 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NCOA6 RESF1 SEC24B BAG3 AHR NAV2 NCOA1 STAM KLF4 CREBBP GARRE1 EP300 RASAL2 | 1.65e-07 | 822 | 68 | 13 | M6782 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.63e-06 | 429 | 68 | 9 | M29 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.90e-06 | 323 | 68 | 8 | M9150 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 1.12e-05 | 294 | 68 | 7 | M40873 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 1.31e-05 | 199 | 68 | 6 | M4526 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 1.35e-05 | 200 | 68 | 6 | M9490 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 3.81e-05 | 145 | 68 | 5 | M1810 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.56e-05 | 157 | 68 | 5 | M7733 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 9.55e-05 | 176 | 68 | 5 | M8248 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 1.51e-04 | 194 | 68 | 5 | M3321 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.70e-04 | 199 | 68 | 5 | M3177 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 1.71e-04 | 316 | 68 | 6 | M2248 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_DN | 1.74e-04 | 200 | 68 | 5 | M3355 | |
| Coexpression | GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN | 1.74e-04 | 200 | 68 | 5 | M9071 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 1.75e-04 | 107 | 68 | 4 | MM947 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 1.83e-04 | 320 | 68 | 6 | MM1063 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29 | 1.84e-04 | 8 | 68 | 2 | M762 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 1.88e-04 | 109 | 68 | 4 | M2451 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 2.16e-04 | 113 | 68 | 4 | M2291 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | RESF1 ATRX ATXN2 BICRA FAM222B NAV2 SCAF11 R3HDM1 ARID1A CREBBP RASAL2 | 4.57e-05 | 804 | 68 | 11 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RESF1 ATRX ATXN2 WDR33 FAM222B NAV2 SCAF11 R3HDM1 ARID1A CREBBP RASAL2 | 4.68e-05 | 806 | 68 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SLITRK2 TUT4 RESF1 ATRX BICRA FAM222B SCAF11 R3HDM1 ARID1A CREBBP RASAL2 | 5.17e-05 | 815 | 68 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.20e-04 | 150 | 68 | 5 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.44e-04 | 156 | 68 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TET2 NCOA6 TUT4 RESF1 TOX ATRX USP9X NAF1 MBNL1 SMARCC2 TAB2 R3HDM1 ARID1A | 1.47e-04 | 1252 | 68 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.72e-04 | 162 | 68 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.72e-04 | 629 | 68 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.81e-04 | 259 | 68 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | KMT2C RESF1 ATRX ATXN2 FAM222B NAV2 SCAF11 R3HDM1 CREBBP RASAL2 | 2.08e-04 | 795 | 68 | 10 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.50e-04 | 275 | 68 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ZBP1 TUT4 ARPP21 TOX EGFR WDR33 FAM222B BANP AHR KLF4 CREBBP | 2.58e-04 | 978 | 68 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.80e-04 | 281 | 68 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 3.87e-04 | 107 | 68 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.20e-10 | 198 | 68 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 68 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-08 | 196 | 68 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-08 | 200 | 68 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-07 | 182 | 68 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-07 | 185 | 68 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.07e-07 | 186 | 68 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.07e-07 | 186 | 68 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-07 | 193 | 68 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 195 | 68 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.23e-07 | 200 | 68 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 152 | 68 | 5 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 152 | 68 | 5 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-06 | 165 | 68 | 5 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-06 | 165 | 68 | 5 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-06 | 165 | 68 | 5 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 173 | 68 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 173 | 68 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 173 | 68 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-06 | 175 | 68 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.66e-06 | 186 | 68 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 192 | 68 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.15e-05 | 193 | 68 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.18e-05 | 194 | 68 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 195 | 68 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.27e-05 | 197 | 68 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 133 | 68 | 4 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 138 | 68 | 4 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 138 | 68 | 4 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.77e-05 | 148 | 68 | 4 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.77e-05 | 148 | 68 | 4 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 151 | 68 | 4 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 9.30e-05 | 155 | 68 | 4 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 9.53e-05 | 156 | 68 | 4 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.53e-05 | 156 | 68 | 4 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 9.53e-05 | 156 | 68 | 4 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 159 | 68 | 4 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-04 | 163 | 68 | 4 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-04 | 163 | 68 | 4 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.21e-04 | 166 | 68 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | COPD-Lymphoid-ILC_B|COPD / Disease state, Lineage and Cell class | 1.21e-04 | 166 | 68 | 4 | 7609671e453280c6e522e9f659c06aab8be81945 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-04 | 169 | 68 | 4 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 169 | 68 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 169 | 68 | 4 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 169 | 68 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 170 | 68 | 4 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.36e-04 | 171 | 68 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 171 | 68 | 4 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.39e-04 | 172 | 68 | 4 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 1.39e-04 | 172 | 68 | 4 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 172 | 68 | 4 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 173 | 68 | 4 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 173 | 68 | 4 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 173 | 68 | 4 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.48e-04 | 175 | 68 | 4 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 175 | 68 | 4 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 176 | 68 | 4 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 176 | 68 | 4 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.58e-04 | 178 | 68 | 4 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-04 | 179 | 68 | 4 | fad1fbee002fcd424c03460d695559060ce41a3f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 179 | 68 | 4 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-04 | 179 | 68 | 4 | 6d4e4b64e633b2ae8514ffa1e45829d6508dac54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-04 | 179 | 68 | 4 | 61a7cc01fae4115325fce0efaa5bacf8f9af5ba2 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.65e-04 | 180 | 68 | 4 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.65e-04 | 180 | 68 | 4 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 180 | 68 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 1.72e-04 | 182 | 68 | 4 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.76e-04 | 183 | 68 | 4 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-04 | 184 | 68 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 184 | 68 | 4 | 6ce9aea2c1c9098f37bdf5135b5e2192ef03b50b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-04 | 184 | 68 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 184 | 68 | 4 | 895f7492d47c4782809bbb125c258127de04f888 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.83e-04 | 185 | 68 | 4 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.83e-04 | 185 | 68 | 4 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-04 | 186 | 68 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.91e-04 | 187 | 68 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 187 | 68 | 4 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.95e-04 | 188 | 68 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-04 | 188 | 68 | 4 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 188 | 68 | 4 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.95e-04 | 188 | 68 | 4 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 68 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.99e-04 | 189 | 68 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.99e-04 | 189 | 68 | 4 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.99e-04 | 189 | 68 | 4 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.36e-05 | 50 | 45 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Drug | AC1L2E0P | 3.22e-07 | 307 | 68 | 9 | CID000019390 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 7.86e-07 | 171 | 68 | 7 | 7535_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.50e-07 | 173 | 68 | 7 | 4458_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.83e-07 | 174 | 68 | 7 | 1659_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.11e-06 | 180 | 68 | 7 | 4541_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.28e-06 | 184 | 68 | 7 | 5671_DN | |
| Drug | anacardic acid | 1.88e-06 | 30 | 68 | 4 | CID000167551 | |
| Drug | 2,3,4,7,8-pentachlorodibenzofuran | 3.00e-06 | 75 | 68 | 5 | ctd:C038890 | |
| Drug | AC1L1COZ | 7.39e-06 | 90 | 68 | 5 | CID000001996 | |
| Drug | AC1L1GHE | 1.01e-05 | 96 | 68 | 5 | CID000003684 | |
| Drug | AC1L1G5B | 1.08e-05 | 46 | 68 | 4 | CID000003531 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.18e-05 | 170 | 68 | 6 | 1050_DN | |
| Drug | In-G | 1.18e-05 | 170 | 68 | 6 | CID000446054 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.27e-05 | 172 | 68 | 6 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.31e-05 | 173 | 68 | 6 | 4237_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.40e-05 | 175 | 68 | 6 | 1014_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.40e-05 | 175 | 68 | 6 | 1058_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.44e-05 | 176 | 68 | 6 | 4632_DN | |
| Drug | Asbestos, Crocidolite | TRERF1 ARID1B CALB2 EGFR GRAP2 AHR NAV2 NCOA1 SMARCC2 MAML2 ARID1A KLF4 MAML3 RASAL2 | 1.47e-05 | 1241 | 68 | 14 | ctd:D017638 |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.49e-05 | 177 | 68 | 6 | 1645_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.59e-05 | 179 | 68 | 6 | 5822_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.74e-05 | 182 | 68 | 6 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.74e-05 | 182 | 68 | 6 | 5802_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 2.43e-05 | 193 | 68 | 6 | 3672_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 2.50e-05 | 194 | 68 | 6 | 7538_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 2.57e-05 | 195 | 68 | 6 | 3670_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.57e-05 | 195 | 68 | 6 | 3669_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | 2.57e-05 | 195 | 68 | 6 | 5093_DN | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 2.65e-05 | 196 | 68 | 6 | 2976_DN | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.65e-05 | 196 | 68 | 6 | 4491_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 3717_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; PC3; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 3675_DN | |
| Drug | CV-1 | 4.22e-05 | 213 | 68 | 6 | CID000130105 | |
| Drug | galangin | 5.13e-05 | 68 | 68 | 4 | ctd:C037032 | |
| Drug | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | 7.91e-05 | 28 | 68 | 3 | ctd:C475093 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 8.74e-05 | 5 | 68 | 2 | ctd:C575894 | |
| Drug | Aldosterone | 9.24e-05 | 79 | 68 | 4 | ctd:D000450 | |
| Drug | fulvestrant | 9.51e-05 | 484 | 68 | 8 | ctd:C070081 | |
| Drug | geldanamycin | 1.19e-04 | 371 | 68 | 7 | ctd:C001277 | |
| Drug | 1,2,3,4,7,8-hexachlorodibenzofuran | 1.31e-04 | 6 | 68 | 2 | ctd:C051412 | |
| Drug | acetone hydrazone | 1.31e-04 | 6 | 68 | 2 | CID000078937 | |
| Drug | androstan-3-ol | 1.31e-04 | 6 | 68 | 2 | ctd:C000658 | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.40e-04 | 166 | 68 | 5 | 2885_UP | |
| Drug | brequinar | 1.43e-04 | 34 | 68 | 3 | CID000057030 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.69e-04 | 173 | 68 | 5 | 5950_DN | |
| Drug | Nicotine | KMT2C TUT4 GALE ARPP21 ATRX EGFR SCAF11 ARID1A KAT6B KLF4 GAB1 | 1.71e-04 | 1000 | 68 | 11 | ctd:D009538 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.74e-04 | 174 | 68 | 5 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.74e-04 | 174 | 68 | 5 | 5065_DN | |
| Drug | 6-chrysenamine | 1.83e-04 | 7 | 68 | 2 | ctd:C100101 | |
| Drug | silver-sulfide (Ag2S | 1.83e-04 | 7 | 68 | 2 | CID000030686 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.83e-04 | 176 | 68 | 5 | 7499_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.83e-04 | 176 | 68 | 5 | 6546_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.88e-04 | 177 | 68 | 5 | 873_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.88e-04 | 177 | 68 | 5 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.88e-04 | 177 | 68 | 5 | 5308_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.88e-04 | 177 | 68 | 5 | 7047_DN | |
| Drug | TCPOBOP | 1.89e-04 | 95 | 68 | 4 | CID000005382 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.93e-04 | 178 | 68 | 5 | 7245_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 1.93e-04 | 178 | 68 | 5 | 4444_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.93e-04 | 178 | 68 | 5 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.98e-04 | 179 | 68 | 5 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.04e-04 | 180 | 68 | 5 | 3688_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.04e-04 | 180 | 68 | 5 | 6886_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.09e-04 | 181 | 68 | 5 | 6951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.14e-04 | 182 | 68 | 5 | 1951_DN | |
| Drug | 5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxyphenyl)-5'-benzimidazolyl)benzimidazole | 2.16e-04 | 39 | 68 | 3 | ctd:C477187 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.25e-04 | 184 | 68 | 5 | 2321_DN | |
| Drug | TiNi | 2.30e-04 | 100 | 68 | 4 | CID000159408 | |
| Drug | AC1N0FHX | 2.43e-04 | 8 | 68 | 2 | CID003916227 | |
| Drug | AC1LCVO8 | 2.43e-04 | 8 | 68 | 2 | CID000656891 | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 2.55e-04 | 189 | 68 | 5 | 3690_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.68e-04 | 191 | 68 | 5 | 7503_DN | |
| Drug | Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.68e-04 | 191 | 68 | 5 | 5344_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.74e-04 | 192 | 68 | 5 | 5058_DN | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 2.81e-04 | 193 | 68 | 5 | 7084_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 2.81e-04 | 193 | 68 | 5 | 7097_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.81e-04 | 193 | 68 | 5 | 5107_DN | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | 2.88e-04 | 194 | 68 | 5 | 6555_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.95e-04 | 195 | 68 | 5 | 3663_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 1628_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A | 3.02e-04 | 196 | 68 | 5 | 1967_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 2367_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 5102_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 7015_UP | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 4182_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.09e-04 | 197 | 68 | 5 | 2903_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.09e-04 | 197 | 68 | 5 | 4024_UP | |
| Drug | rofecoxib; Down 200; 10uM; PC3; HG-U133A | 3.09e-04 | 197 | 68 | 5 | 463_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 3.09e-04 | 197 | 68 | 5 | 1441_UP | |
| Drug | zoxazolamine | 3.09e-04 | 44 | 68 | 3 | CID000006103 | |
| Drug | 1-chlorobutane | 3.12e-04 | 9 | 68 | 2 | CID000008005 | |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 4584_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 2294_UP | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 5094_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | 3.16e-04 | 198 | 68 | 5 | 1609_DN | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 6799_UP | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 7064_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 5289_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 7279_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 3764_DN | |
| Disease | Adenoid Cystic Carcinoma | 3.05e-09 | 100 | 67 | 7 | C0010606 | |
| Disease | Sezary Syndrome | 4.10e-07 | 27 | 67 | 4 | C0036920 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.31e-06 | 41 | 67 | 4 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 2.31e-06 | 41 | 67 | 4 | C0007138 | |
| Disease | Breast adenocarcinoma | 2.31e-06 | 41 | 67 | 4 | C0858252 | |
| Disease | Coffin-Siris syndrome | 3.15e-06 | 13 | 67 | 3 | C0265338 | |
| Disease | Malignant neoplasm of breast | TRERF1 NCOA6 ARID1B EGFR AHR NCOA1 MAP3K13 ARID1A KAT6B EP300 GAB1 RASAL2 | 4.81e-06 | 1074 | 67 | 12 | C0006142 |
| Disease | Menke-Hennekam syndrome | 5.08e-06 | 2 | 67 | 2 | cv:C5681632 | |
| Disease | Acute myeloid leukemia with t(8;16)(p11;p13) translocation | 5.08e-06 | 2 | 67 | 2 | C4511003 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 5.08e-06 | 2 | 67 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 5.08e-06 | 2 | 67 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.08e-06 | 2 | 67 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.08e-06 | 2 | 67 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 5.08e-06 | 2 | 67 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 5.08e-06 | 2 | 67 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | CHROMOSOME 6q24-q25 DELETION SYNDROME | 5.08e-06 | 2 | 67 | 2 | C3150215 | |
| Disease | Rubinstein-Taybi Syndrome | 5.08e-06 | 2 | 67 | 2 | C0035934 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.51e-06 | 195 | 67 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 7.54e-06 | 206 | 67 | 6 | C0152013 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.65e-05 | 139 | 67 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 1.71e-05 | 140 | 67 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.77e-05 | 141 | 67 | 5 | C0005684 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.19e-05 | 24 | 67 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.19e-05 | 24 | 67 | 3 | C3805278 | |
| Disease | Cholangiocarcinoma | 2.80e-05 | 26 | 67 | 3 | C0206698 | |
| Disease | Breast Carcinoma | 2.94e-05 | 538 | 67 | 8 | C0678222 | |
| Disease | Leukemia, Myelocytic, Acute | 4.71e-05 | 173 | 67 | 5 | C0023467 | |
| Disease | left ventricular structural measurement | 4.90e-05 | 88 | 67 | 4 | EFO_0008205 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.06e-05 | 5 | 67 | 2 | C3281201 | |
| Disease | Klatskin's tumor (is_implicated_in) | 5.06e-05 | 5 | 67 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 6.62e-05 | 95 | 67 | 4 | C0279626 | |
| Disease | Mitral valve prolapse | 7.57e-05 | 36 | 67 | 3 | HP_0001634 | |
| Disease | Abnormal corpus callosum morphology | 7.57e-05 | 6 | 67 | 2 | C1842581 | |
| Disease | Prostatic Neoplasms | 7.61e-05 | 616 | 67 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.61e-05 | 616 | 67 | 8 | C0376358 | |
| Disease | Pancreatic Neoplasm | 8.08e-05 | 100 | 67 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 8.73e-05 | 102 | 67 | 4 | C0346647 | |
| Disease | coffee consumption measurement, tea consumption measurement | 1.39e-04 | 44 | 67 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | Congenital Heart Defects | 1.39e-04 | 44 | 67 | 3 | C0018798 | |
| Disease | Neuroblastoma | 1.69e-04 | 47 | 67 | 3 | C0027819 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 1.81e-04 | 9 | 67 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | neuroblastoma (is_implicated_in) | 2.26e-04 | 10 | 67 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.29e-04 | 131 | 67 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.29e-04 | 131 | 67 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 2.29e-04 | 131 | 67 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 2.29e-04 | 131 | 67 | 4 | C3714758 | |
| Disease | Small cell carcinoma of lung | 2.55e-04 | 54 | 67 | 3 | C0149925 | |
| Disease | Juvenile-Onset Still Disease | 2.57e-04 | 135 | 67 | 4 | C0087031 | |
| Disease | Alcoholic Intoxication, Chronic | 3.63e-04 | 268 | 67 | 5 | C0001973 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 4.54e-04 | 14 | 67 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 4.62e-04 | 66 | 67 | 3 | DOID:3459 (is_marker_for) | |
| Disease | caffeine measurement | 5.23e-04 | 15 | 67 | 2 | EFO_0021177 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 5.23e-04 | 15 | 67 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | blood urea nitrogen measurement | 5.67e-04 | 452 | 67 | 6 | EFO_0004741 | |
| Disease | testosterone measurement | TET2 NCOA6 ARID1B MBNL1 BANP NCOA1 R3HDM2 PTPN21 ARID1A SS18 | 5.77e-04 | 1275 | 67 | 10 | EFO_0004908 |
| Disease | Endometrial Carcinoma | 5.97e-04 | 72 | 67 | 3 | C0476089 | |
| Disease | stomach cancer (is_implicated_in) | 5.97e-04 | 72 | 67 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | T-Cell Lymphoma | 5.97e-04 | 16 | 67 | 2 | C0079772 | |
| Disease | apolipoprotein A 1 measurement | 6.57e-04 | 848 | 67 | 8 | EFO_0004614 | |
| Disease | maximum cigarettes per day measurement | 7.59e-04 | 18 | 67 | 2 | EFO_0009264 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 8.11e-04 | 80 | 67 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 9.35e-04 | 84 | 67 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 1.04e-03 | 21 | 67 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Colorectal Carcinoma | 1.06e-03 | 702 | 67 | 7 | C0009402 | |
| Disease | neutrophil count | TRERF1 TET2 ATXN2 WDR33 MBNL1 NCOA1 R3HDM1 ARID1A CREBBP TULP3 | 1.07e-03 | 1382 | 67 | 10 | EFO_0004833 |
| Disease | platelet crit | 1.38e-03 | 952 | 67 | 8 | EFO_0007985 | |
| Disease | free androgen index | 1.62e-03 | 374 | 67 | 5 | EFO_0007005 | |
| Disease | neutrophil count, basophil count | 1.70e-03 | 224 | 67 | 4 | EFO_0004833, EFO_0005090 | |
| Disease | taste liking measurement | 1.90e-03 | 388 | 67 | 5 | EFO_0010155 | |
| Disease | central nervous system cancer, glioma | 1.98e-03 | 29 | 67 | 2 | EFO_0000326, EFO_0005543 | |
| Disease | Hematopoetic Myelodysplasia | 1.98e-03 | 29 | 67 | 2 | C2713368 | |
| Disease | breast carcinoma | 2.12e-03 | 1019 | 67 | 8 | EFO_0000305 | |
| Disease | cancer | 2.17e-03 | 400 | 67 | 5 | MONDO_0004992 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPQPQPQALHYALAN | 361 | Q8N9N5 | |
| PEPQHTHVGQMQYNP | 776 | P35869 | |
| THVGQMQYNPVLPGQ | 781 | P35869 | |
| LGLPYQVNQMPTQPQ | 471 | Q09472 | |
| GVGYPPQQQQRMQHH | 2216 | Q09472 | |
| PYMNQPQTQLQPQVP | 491 | Q92793 | |
| AKYVANQPGMQPQPG | 2106 | Q92793 | |
| PQGQALNIMNPGHNP | 2166 | Q92793 | |
| PGHNPNMASMNPQYR | 2176 | Q92793 | |
| MQYPQQQMPPQYGQQ | 656 | Q8NFD5 | |
| PQQAARMPYQQALHP | 486 | Q6P1W5 | |
| GLPQQSYQQPIMLPN | 736 | Q9UBL0 | |
| QQGYIQQPSPQMPAC | 631 | Q15032 | |
| PQQQPPLNNHMISQA | 421 | Q9Y2K5 | |
| HAPPTQQVLPPQGYM | 496 | Q9Y2K5 | |
| NQHPHPMQSQYPALP | 611 | Q33E94 | |
| QPYAQQPMQTPPHGN | 2031 | Q8WYB5 | |
| PAQARQQPPQHYLQV | 751 | Q99743 | |
| NSIQNRPPGYPNMNQ | 906 | O14497 | |
| NYQPPPSMQNHIPQV | 1571 | O14497 | |
| MQPQVPPLHYQGQSR | 356 | O43474 | |
| DFMQPLGPLQQSPQH | 3461 | Q8NEZ4 | |
| PQYPGLQQAQTMPQG | 1926 | Q86YW9 | |
| ANPNKNPLMPYIQQQ | 621 | Q96JK9 | |
| NYVPMNPNSPPRQHS | 446 | Q13480 | |
| YSPQQFPNQPLVQHV | 1041 | Q99700 | |
| NVPPQIALPMYQQLQ | 186 | Q9P287 | |
| QQPQGLGHPQPMAQT | 191 | Q8WU58 | |
| FQNPVYHLNNPIPAM | 781 | Q9UJF2 | |
| AFPAQQQPLQQIHMG | 456 | Q6ZTU2 | |
| YNINQGRFQPPHVQM | 61 | O15442 | |
| NSLNNPQPYLQPSPM | 401 | Q16825 | |
| FINNPHPAMEPRQGN | 541 | Q8IZL2 | |
| SLQQQYQQPPPAMSQ | 636 | O43283 | |
| VMQQQPPNQGPQSLH | 491 | Q14686 | |
| GPNNMPSHVVLPQNQ | 1146 | Q14686 | |
| QAYTQQPMQPNPHGN | 1961 | Q92794 | |
| PQGIPNNLMPYVSQV | 201 | Q14376 | |
| QNPVYHNQPLNPAPS | 1106 | P00533 | |
| PPNLIMNPSNYQQID | 2441 | P46100 | |
| KMHYQNGQAPPPVFL | 581 | P29322 | |
| VQQHQQYPMPELGRA | 26 | O15063 | |
| NMQLQQHTAFLPPVP | 326 | Q9NR56 | |
| MAGPQQQPPYLHLAE | 1 | P22676 | |
| QQHQHQPQPPQYAPA | 196 | O75791 | |
| RQVHPFHVYPQPGMQ | 106 | O95817 | |
| PAQHMLPGQNQFLLP | 461 | Q9NZM4 | |
| PAQNQMQVPSGYGLH | 46 | O95487 | |
| AQHQPMNIFPYPVGV | 1221 | Q99590 | |
| VFSMQHPPPQQAPNQ | 426 | Q10571 | |
| NLPNGYMTDLQRPQP | 16 | P17600 | |
| QPYTGPAAHHMNNPQ | 2516 | Q93008 | |
| VNMNPAPNPAVYNPE | 311 | Q12972 | |
| QMYENILHQPLQIPG | 241 | Q9HBY8 | |
| VSQFNPMNPQQVYQP | 236 | Q9NYJ8 | |
| MYPGNSNPISQPLLN | 51 | Q9HCM1 | |
| QNQPTPAQPGVYNNM | 1301 | Q15788 | |
| VSVQLPQPQQQYNHP | 676 | Q8IVL1 | |
| NYIPPPVGQMCQNPI | 686 | Q9H156 | |
| FQQMHQQQQQPPPAL | 951 | Q8TAQ2 | |
| NGQMYCPKEQAQPPH | 286 | P31271 | |
| PVNQGRHYQKEMNPP | 601 | Q6ZVT6 | |
| YQHNPINMICQNGPN | 181 | Q9H171 | |
| NPQVAQHPMAPYRVL | 256 | Q8N443 | |
| NQGPMMHQQPPSQQY | 201 | Q15532 | |
| MHQQPPSQQYNMPQG | 206 | Q15532 | |
| TLYQNAGPNMPQVPN | 496 | Q92783 | |
| LGVLVNPNMYQSPPQ | 376 | Q15650 | |
| QGPMSQIPQGFQQPH | 591 | Q9C0J8 | |
| QIPQGFQQPHPSQQM | 596 | Q9C0J8 | |
| LMDPGYVNVQPQPQE | 66 | Q96GR4 | |
| QGAQPPHQVQMPLYN | 1461 | Q5TAX3 | |
| PHQVQMPLYNFPQSP | 1466 | Q5TAX3 | |
| SSNPMNPYPGLLNQN | 1611 | Q6N021 | |
| HQPLTMQQPLGNQLP | 436 | O94900 | |
| PGMTLNHKQIPYQPQ | 326 | O75386 | |
| QQQMHLQPPSYHRDP | 341 | Q96PN7 | |
| SQRQNNPIMPQYPFP | 411 | Q96HR8 | |
| PQHHPPMAQNLQYPD | 406 | Q15223 |